Datum Källa Rubrik Typ Alternativ
2024-06-19 Ziccum Ziccum signs Evaluation agreement with ReCode Therapeutics for LaminarPace mRNA study Pressreleaser Ladda ner | Visa Stäng
2024-06-11 Ziccum Ziccum reports on developments in the portfolio of industry partner projects Pressreleaser Ladda ner | Visa Stäng
2024-06-03 Ziccum Exercise of Employee Stock Options of Series LTI 2021:1 at Ziccum AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-05-29 Ziccum Kommuniké från årsstämma i Ziccum AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-05-29 Ziccum Bulletin from the Annual General Meeting of Ziccum AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-05-28 Ziccum Ziccum partners with Dagens Industri for Investor Relations program Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 28 May 2024 | Ziccum

Ziccum partners with Dagens Industri for Investor Relations program

Ziccum partners with Dagens Industri, the largest Nordic business paper, to improve shareholders’ access to news updates and raise broader awareness of its continuous scientific and commercial progress.

Ziccum AB has signed a partnership with the Investor Relations arm of Dagens Industri, joining a select group of Nordic SMEs in a bid to ensure timely, efficient, and professional dissemination of its increasing information flow. The scope includes interviews in text and video format as well as company coverage in smaller and larger features in the main DI paper.

Operating at the cutting edge of science, developing a disruptive technology enabling new and much improved biopharmaceuticals and continuously gaining increased recognition from international Pharma & Biotech industry, Ziccum sees the need to keep its loyal regional investor base well-apprised by providing systematic and accessible updates on its progress. Ziccum could not ask for a better partner than Dagens Industri, an institution of business reporting among the Nordic investment community for decades.

Ziccum’s CEO, Ann Gidner: “Now that Dagens Industri are selecting a few smaller Swedish listed companies to be well featured, we are delighted to be included and it is perfect timing with our need for better visibility in investors’ circles”.

About Dagens Industri:

Dagens Industri was founded in 1976 and is currently owned by the Swedish media group Bonnier AB. DI’s online edition, di.se, has been consistently voted as Sweden’s “best economics online site” for 20 years (from 1999 to 2019) in a competition held by the PR firm Hallvarsson & Halvarsson.

2024-05-23 Ziccum KOMPLETTERING TILL KALLELSEN TILL ÅRSSTÄMMA I ZICCUM AB (PUBL), ATT HÅLLAS DEN 29 MAJ 2024, KL. 15.00 I BOLAGETS LOKALER PÅ SCHEELEVÄGEN 22 I LUND Pressreleaser Ladda ner | Visa Stäng
2024-05-06 Ziccum Ziccum CEO Analyst video interview: Q1, 2024 highlights Pressreleaser Ladda ner | Visa Stäng
2024-04-30 Ziccum Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy Pressreleaser Ladda ner | Visa Stäng
2024-04-29 Ziccum Ziccum AB (publ) Interim report Q1 2024 Rapporter Ladda ner | Visa Stäng
2024-04-26 Ziccum Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out Pressreleaser Ladda ner | Visa Stäng
2024-04-25 Ziccum KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2024-04-15 Ziccum Ziccum AB (publ) releases Annual Report 2023 Rapporter Ladda ner | Visa Stäng
2024-04-15 Ziccum Ziccum AB (publ) publicerar Årsredovisning 202 Rapporter Ladda ner | Visa Stäng
2024-04-10 Ziccum Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City Pressreleaser Ladda ner | Visa Stäng
2024-04-03 Ziccum Ziccum strengthens and streamlines business and finance functions Pressreleaser Ladda ner | Visa Stäng
2024-03-28 Ziccum Ziccum-presentation och VD-intervju från Kapitalmarknadsdag nu tillgängliga Pressreleaser Ladda ner | Visa Stäng
2024-03-14 Ziccum Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace Pressreleaser Ladda ner | Visa Stäng
2024-03-01 Ziccum Ziccum reports significant progress in 3D-modelling project with model completion Pressreleaser Ladda ner | Visa Stäng
2024-02-26 Ziccum Ziccum meddelar sista dag för handel med BTU Pressreleaser Ladda ner | Visa Stäng
2024-02-26 Ziccum Ziccum announces last day of trading in BTU Pressreleaser Ladda ner | Visa Stäng
2024-02-16 Ziccum Ziccum offentliggör utfall i företrädesemission Pressreleaser Ladda ner | Visa Stäng
2024-02-16 Ziccum Ziccum announces outcome in rights issue Pressreleaser Ladda ner | Visa Stäng
2024-02-12 Ziccum Ziccums CEO Ann Gidner in Fireside Chat on mRNA development hosted by US Force Family Office Pressreleaser Ladda ner | Visa Stäng
2024-02-12 Ziccum Ziccums VD Ann Gidner i paneldiskussion om mRNA arrangerat av amerikanska Force Family Office Pressreleaser Ladda ner | Visa Stäng
2024-02-09 Ziccum Sista dag för handel med uniträtter i Ziccum Pressreleaser Ladda ner | Visa Stäng
2024-02-09 Ziccum Last day for trading in unit rights in Ziccum Pressreleaser Ladda ner | Visa Stäng
2024-02-08 Ziccum Ziccums Styrelse och Ledningsgrupp nyttjar samtliga sina Uniträtter i den pågående nyemissionen. Pressreleaser Ladda ner | Visa Stäng
2024-02-08 Ziccum Ziccum's Board of Directors and Management Group use all their Unit Rights in the ongoing new share issue. Pressreleaser Ladda ner | Visa Stäng
2024-02-05 Ziccum Ziccum CEO videointervju: mRNA i fokus Pressreleaser Ladda ner | Visa Stäng
2024-02-05 Ziccum Ziccum CEO video interview: mRNA in focus Pressreleaser Ladda ner | Visa Stäng
2024-02-03 Ziccum Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th Pressreleaser Ladda ner | Visa Stäng
2024-02-03 Ziccum Välkommen till 'Invest Live' för att se Ziccums VD Ann Gidner presentera bolaget, som hålls live med efterföljande frågestund, tisdag den 6 februari Pressreleaser Ladda ner | Visa Stäng
2024-02-01 Ziccum Ziccums Q4-rapport – VD-uppdatering på svenska Pressreleaser Ladda ner | Visa Stäng
2024-01-31 Ziccum Ziccum has proven excellent mRNA activity in animal study with LaminarPace material Pressreleaser Ladda ner | Visa Stäng
2024-01-31 Ziccum Ziccums VD i videointervju med Eucaps Pressreleaser Ladda ner | Visa Stäng
2024-01-30 Ziccum Ziccum launches IR calendar for coming weeks Pressreleaser Ladda ner | Visa Stäng
2024-01-30 Ziccum Ziccum offentliggör informationsmemorandum med anledning av förestående företrädesemission av units Pressreleaser Ladda ner | Visa Stäng
2024-01-30 Ziccum Ziccum publishes Information Memorandum in connection with the forthcoming rights issue of units Pressreleaser Ladda ner | Visa Stäng
2024-01-26 Ziccum ZICCUM AB (publ) Year-End report Q4 2023 Rapporter Ladda ner | Visa Stäng
2024-01-22 Ziccum Ziccum säkrar finansiering till 2025 genom kombinerad riktad emission och företrädesemission för fortsatt genomförande av den ambitiösa affärsplanen. Pressreleaser Ladda ner | Visa Stäng
2024-01-22 Ziccum Ziccum secures financing into 2025 through a combined directed share issue and rights issue to finance the continued execution of its ambitious business plan Pressreleaser Ladda ner | Visa Stäng
2024-01-10 Ziccum Ziccum reports successful mRNA/LNP Feasibility Study with major Biotech Corporation Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Ziccum CEO's Seasons Greetings 2023: A pivotal year of significant results Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Ziccum VDs Julhälsning 2023: Ett avgörande år med betydande resultat Pressreleaser Ladda ner | Visa Stäng
2023-12-04 Ziccum Ziccum signs Academic Collaboration with University of Copenhagen on inhalable mRNA vaccine project Pressreleaser Ladda ner | Visa Stäng
2023-12-01 Ziccum Ziccum to present at ‘Inhaled Biologics’ live webinar with KOL Assoc Prof. Per Gerde Pressreleaser Ladda ner | Visa Stäng
2023-11-30 Ziccum Ziccum AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-28 Ziccum Feasibility studies and continued revenue generation after third agreement signed with leading industry player: CEO Interview Pressreleaser Ladda ner | Visa Stäng
2023-11-27 Ziccum Ziccum AB: BioStock: Ziccum har säkrat avtal inom alla tre marknadssegment Pressreleaser Visa Stäng
2023-11-09 Ziccum Ziccum launches News portal Pressreleaser Ladda ner | Visa Stäng
2023-11-08 Ziccum Ziccum CEO Analyst video interview: new industry Agreement, Q3 highlights Pressreleaser Ladda ner | Visa Stäng
2023-11-07 Ziccum Ziccum signs agreement for Vaccine Evaluation project with major US Biomanufacturing corporation Pressreleaser Ladda ner | Visa Stäng
2023-10-27 Ziccum Ziccums Q3-rapport – VD-uppdatering på svenska Pressreleaser Ladda ner | Visa Stäng
2023-10-25 Ziccum ZICCUM AB (publ) Interim report Q3 2023 Rapporter Ladda ner | Visa Stäng
2023-10-23 Ziccum Ziccum reports positive results from external validation of mRNA activity after LaminarPace treatment Pressreleaser Ladda ner | Visa Stäng
2023-10-18 Ziccum Ziccum AB: Ziccum presenterar på BioStock Life Science Summit den 25 oktober Pressreleaser Visa Stäng
2023-09-05 Ziccum Ziccum appoints senior biotech manager as new COO Pressreleaser Ladda ner | Visa Stäng
2023-08-29 Ziccum Ziccum CEO Analyst interview part 2 Pressreleaser Ladda ner | Visa Stäng
2023-08-25 Ziccum Analyst interview with Ziccum CEO on significant milestones achieved Pressreleaser Ladda ner | Visa Stäng
2023-08-17 Ziccum Ziccum to present at Investor Conference BioFuture 2023 in New York Pressreleaser Ladda ner | Visa Stäng
2023-07-24 Ziccum Ziccum säkrar andra Feasibility-avtalet på två månader: VD-intervju på svenska Pressreleaser Ladda ner | Visa Stäng
2023-07-20 Ziccum Ziccums Q2-rapport - VD-uppdatering på svenska Pressreleaser Ladda ner | Visa Stäng
2023-07-18 Ziccum ZICCUM AB (publ) Interim report Q2 2023 Rapporter Ladda ner | Visa Stäng
2023-07-17 Ziccum Ziccum signs Evaluation Agreement for Feasibility Study with major global Pharmaceutical Corporation Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

29 Jan 2025 | Bokslutskommuniké 2024